
Jessica Fye
Stock Analyst at J.P. Morgan
(4.15)
# 1,667
Out of 5,184 analysts
620
Total ratings
54.3%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Rated: Hold | $79 → $81 | $91.35 | -11.33% | 22 | Nov 20, 2026 | |
| BNTX BioNTech SE | Rated: Hold | $93 | $80.96 | +14.87% | 34 | Nov 19, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $445 → $460 | $390.94 | +17.67% | 16 | Nov 19, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $369 → $254 | $143.82 | +76.61% | 30 | Nov 18, 2026 | |
| MRNA Moderna | Reiterated: Sell | $102 | $195.00 | -47.69% | 26 | Nov 16, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | n/a | $96.13 | - | 18 | Nov 9, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $87 → $86 | $60.41 | +42.36% | 19 | Nov 4, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $300 → $310 | $230.26 | +34.63% | 36 | Nov 3, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $560 → $570 | $515.02 | +10.68% | 23 | Nov 3, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $710 → $695 | $554.73 | +25.29% | 36 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $252.73 | - | 52 | Oct 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 → $33 | $15.25 | +116.39% | 14 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $12 → $13 | $7.22 | +80.06% | 20 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $120 → $123 | $114.63 | +7.31% | 27 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $141.33 | +23.82% | 29 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $76 → $70 | $26.58 | +163.36% | 34 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $44.94 | - | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $10 → $13 | $10.57 | +22.99% | 11 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | n/a | $5.05 | - | 14 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $26.41 | +89.32% | 15 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $88 | $49.55 | +77.60% | 4 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $65 | $30.20 | +115.23% | 32 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 → $40 | $26.81 | +49.20% | 18 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $16.15 | +104.33% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $18.45 | +57.18% | 18 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $17 | $10.71 | +58.73% | 15 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $48.13 | n/a | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $14 | $26.14 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $1.53 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $19 | $0.9893 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.229 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $84.55 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 → $66 | $160.70 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $7.47 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $7.62 | n/a | 4 | Feb 8, 2018 |
Halozyme Therapeutics
Nov 20, 2026
Rated: Hold
Price Target: $79 → $81
Current: $91.35
Upside: -11.33%
BioNTech SE
Nov 19, 2026
Rated: Hold
Price Target: $93
Current: $80.96
Upside: +14.87%
BeOne Medicines AG
Nov 19, 2026
Reiterated: Buy
Price Target: $445 → $460
Current: $390.94
Upside: +17.67%
Alnylam Pharmaceuticals
Nov 18, 2026
Reiterated: Buy
Price Target: $369 → $254
Current: $143.82
Upside: +76.61%
Moderna
Nov 16, 2026
Reiterated: Sell
Price Target: $102
Current: $195.00
Upside: -47.69%
Mirum Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $96.13
Upside: -
BioMarin Pharmaceutical
Nov 4, 2026
Reiterated: Buy
Price Target: $87 → $86
Current: $60.41
Upside: +42.36%
Jazz Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $300 → $310
Current: $230.26
Upside: +34.63%
Vertex Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $560 → $570
Current: $515.02
Upside: +10.68%
United Therapeutics
Oct 28, 2026
Rated: Buy
Price Target: $710 → $695
Current: $554.73
Upside: +25.29%
Oct 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $252.73
Upside: -
Oct 9, 2026
Reiterated: Hold
Price Target: $35 → $33
Current: $15.25
Upside: +116.39%
Sep 30, 2026
Rated: Hold
Price Target: $12 → $13
Current: $7.22
Upside: +80.06%
Sep 28, 2026
Reiterated: Hold
Price Target: $120 → $123
Current: $114.63
Upside: +7.31%
Sep 28, 2026
Reiterated: Buy
Price Target: $175
Current: $141.33
Upside: +23.82%
Sep 22, 2026
Rated: Buy
Price Target: $76 → $70
Current: $26.58
Upside: +163.36%
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $44.94
Upside: -
Aug 21, 2026
Initiated Coverage: Sell
Price Target: $10 → $13
Current: $10.57
Upside: +22.99%
Aug 21, 2026
Initiated Coverage: Sell
Price Target: n/a
Current: $5.05
Upside: -
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $26.41
Upside: +89.32%
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $49.55
Upside: +77.60%
Aug 21, 2026
Initiated Coverage: Hold
Price Target: $30 → $65
Current: $30.20
Upside: +115.23%
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $25 → $40
Current: $26.81
Upside: +49.20%
Aug 14, 2026
Rated: Buy
Price Target: $33
Current: $16.15
Upside: +104.33%
Aug 11, 2026
Reiterated: Buy
Price Target: $29
Current: $18.45
Upside: +57.18%
Jul 13, 2026
Reiterated: Hold
Price Target: $23 → $17
Current: $10.71
Upside: +58.73%
Oct 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $48.13
Upside: n/a
Jun 7, 2022
Reiterated: Hold
Price Target: $18 → $14
Current: $26.14
Upside: n/a
Apr 7, 2022
Reiterated: Hold
Price Target: $7 → $5
Current: $1.53
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $20 → $19
Current: $0.9893
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.229
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $84.55
Upside: n/a
Apr 6, 2020
Reiterated: Hold
Price Target: $94 → $66
Current: $160.70
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $7.47
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $7.62
Upside: n/a